Axon's innovation, strong revenue growth, and robust software model justify its valuation. Click here to find out why AXON ...

Offloading government responsibilities to AI can encourage discrimination, give wrong advice, and limit access to valid ...

TL;DR: Thomas Keane is now in charge of all things technology at HHS. He’s competent, calm, and about to be thrown into a ...

A former Palantir engineer described how the company interviewed and what it looked for in talent. He said the company sought independent thinkers with broad interests and intense competitiveness.

Palantir has been on fire over the past couple of years, with its rally sparked by strong demand for its artificial intelligence (AI) tools. The run-up in the stock price has been accompanied by ...

Palantir Technologies reported impressive Q1 results, beating Wall Street revenue estimates and raising FY 2025 guidance due to robust U.S. commercial segment growth and AI product uptake. Despite ...

Palantir stock has soared 1,000% over the past three years and is trading at a lofty valuation today. The company continues to wow investors with soaring revenue and a solid balance of growth and ...

Humphrey Building on April 11, 2015 in Washington, D.C. (Photo By Raymond Boyd/Getty Images) Clark Minor, a former Palantir employee, is the chief information officer of the Department of Health and ...

With its shares up 58% year to date, Palantir Technologies (NASDAQ: PLTR) embarrassed its naysayers -- it has been repeatedly testing new highs despite calls of overvaluation. But on some level ...

At a new all-time high, Palantir (NASDAQ: PLTR) is gaining traction. Volume of 111 million is about to cross above its daily average volume of 112.1 million. All as the stock explodes on Saudi ...

Continue » Could investing in IonQ today be like catching Palantir at the onset of the AI revolution? Read on to find out. Over the last 12 months, IonQ has only generated $43 million in sales.

ABC News’ Ike Ejiochi and criminal attorney Lauren Johnson-Norris report on the latest testimony in the Massachusetts courtroom.